Semaglutide causes fatigue in many users, particularly in the first few weeks. The GLP-1 receptor agonist reduces calorie intake rapidly, which can lower energy levels. Nausea and disrupted sleep from gastrointestinal side effects also contribute to tiredness. Most users report fatigue improving after 4–8 weeks as the body adjusts.
Why am I not losing weight on semaglutide?
▼
Weight loss stalls on semaglutide are common and usually caused by the body adapting to lower calorie intake, inadequate protein intake, or not being at a high enough dose. Stress, poor sleep, and medications that affect insulin resistance can also blunt results. Most providers recommend increasing the dose incrementally and reassessing after 12 weeks.
When is the best time to take semaglutide?
▼
Semaglutide injections can be taken any day of the week at any time of day — the specific time matters less than consistency. Many users prefer mornings to monitor side effects during the day, while others inject at night to sleep through initial nausea. Pick a day and time you can stick to weekly.
How soon does semaglutide work?
▼
Most users notice reduced appetite within the first 1–2 weeks of starting semaglutide, even at the starting dose. Measurable weight loss typically begins within 4 weeks. Significant results (5%+ body weight) usually appear by weeks 12–16 at therapeutic doses.
What is the difference between semaglutide and tirzepatide?
▼
Semaglutide is a GLP-1 receptor agonist (brand names: Ozempic, Wegovy). Tirzepatide is a dual GLP-1/GIP receptor agonist (brand names: Mounjaro, Zepbound). Clinical trials show tirzepatide produces greater average weight loss (20–22% vs 15%) but both are highly effective. Tirzepatide tends to be more expensive and has slightly different side effect profiles.
